Platinum-Free Break Enhances Therapy After First Relapse In Ovarian Cancer
Majority Of Americans Would Consider Participating In Clinical Trials, Study Finds
Mesothelioma Survival, QOL Improved With Alimta, Platinol
NCI-Funded Trials Show Aspirin Reduces Recurrence of Polyps
Study Finds Green Tea No Help In Advanced Prostate Cancer
Cancer Screening Priorities Questioned In Dartmouth Study
Regular NSAIDs Use Protects Smokers From Lung Cancer
Women Are Less Active After A Diagnosis of Breast Cancer
NCI-Approved Protocols Listed
Trending Stories
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - Vinay Prasad’s CV inaccurately claims past membership on the President’s Cancer Panel
- CDC’s recommendation to delay infant hepatitis B shot is likely to raise infections, JAMA studies show
- Breakthrough Therapy designation, ASCO plenary, and NEJM publication notwithstanding, breast cancer drug camizestrant gets a No from ODAC
- CBER Director Vinay Prasad dared to “say no to drugs”
- Reforms pending at USPSTF, plus, FDA rejects promising melanoma drug for the second time









